Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Treatment of active tuberculosis: challenges and prospects.

Literature DB >> 15837110

Treatment of active tuberculosis: challenges and prospects.

Abstract

This article reviews the basic principles of drug treatment of tuberculosis, individual pharmacologic agents, current treatment recommendations, and several special situations that clinicians are likely to encounter in medical practice.

Entities: Disease

Mesh：

Substances：
Antitubercular Agents

Year: 2005 PMID： 15837110 DOI： 10.1016/j.ccm.2005.02.011

Source DB: PubMed Journal: Clin Chest Med ISSN： 0272-5231 Impact factor: 2.878

Keyword Cloud
Cited

8 in total

1. Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.

Authors: Sarah Schmidt Grant; Benjamin B Kaufmann; Nikhilesh S Chand; Nathan Haseley; Deborah T Hung
Journal: Proc Natl Acad Sci U S A Date: 2012-07-09 Impact factor: 11.205

2. Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases.

Authors: Clinton R Nishida; Paul R Ortiz de Montellano
Journal: Chem Biol Interact Date: 2010-09-21 Impact factor: 5.192

3. Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery: A Quality by Design Study.

Authors: Elahehnaz Parhizkar; Delaram Sadeghinia; Hamed Hamishehkar; Shadi Yaqoubi; Ali Nokhodchi; Shohreh Alipour
Journal: Adv Pharm Bull Date: 2021-05-18

4. Effect of different oral doses of isoniazid-rifampicin in rats.

Authors: Satya V Rana; Ravinder Pal; Kim Vaiphie; Kartar Singh
Journal: Mol Cell Biochem Date: 2006-04-01 Impact factor: 3.396

5. The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance.

Authors: Ramandeep Singh; Clifton E Barry; Helena I M Boshoff
Journal: J Bacteriol Date: 2010-01-08 Impact factor: 3.490

Treatment of active tuberculosis: challenges and prospects.

1. Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.

2. Bioactivation of antituberculosis thioamide and thiourea prodrugs by bacterial and mammalian flavin monooxygenases.

3. Carrier Effect in Development of Rifampin Loaded Proliposome for Pulmonary Delivery: A Quality by Design Study.

4. Effect of different oral doses of isoniazid-rifampicin in rats.

5. The three RelE homologs of Mycobacterium tuberculosis have individual, drug-specific effects on bacterial antibiotic tolerance.

6. Does directly observed therapy (DOT) reduce drug resistant tuberculosis?

7. Isoniazid prevents Nrf2 translocation by inhibiting ERK1 phosphorylation and induces oxidative stress and apoptosis.

8. Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs.